JP2012527877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012527877A5 JP2012527877A5 JP2012512354A JP2012512354A JP2012527877A5 JP 2012527877 A5 JP2012527877 A5 JP 2012527877A5 JP 2012512354 A JP2012512354 A JP 2012512354A JP 2012512354 A JP2012512354 A JP 2012512354A JP 2012527877 A5 JP2012527877 A5 JP 2012527877A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding
- binding protein
- epitope
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18189309P | 2009-05-28 | 2009-05-28 | |
| US61/181,893 | 2009-05-28 | ||
| PCT/EP2010/057231 WO2010136483A2 (en) | 2009-05-28 | 2010-05-26 | Antigen-binding proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012527877A JP2012527877A (ja) | 2012-11-12 |
| JP2012527877A5 true JP2012527877A5 (cg-RX-API-DMAC7.html) | 2013-07-11 |
| JP5901517B2 JP5901517B2 (ja) | 2016-04-13 |
Family
ID=42671768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012512354A Expired - Fee Related JP5901517B2 (ja) | 2009-05-28 | 2010-05-26 | 抗原結合性タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9394374B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2435482B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5901517B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2763491A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2729422T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010136483A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| CA2906096C (en) * | 2013-03-15 | 2022-03-15 | Omeros Corporation | Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same |
| BR112016011027A2 (pt) * | 2013-12-20 | 2017-12-05 | Genentech Inc | método de produção de um anticorpo, anticorpos, composição farmacêutica, polinucleotídeo, vetor, célula hospedeira, método de tratamento de asma e método de tratamento de um distúrbio |
| AR104368A1 (es) | 2015-04-03 | 2017-07-19 | Lilly Co Eli | Anticuerpos biespecíficos anti-cd20- / anti-baff |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| WO2018083087A2 (en) | 2016-11-02 | 2018-05-11 | Glaxosmithkline Intellectual Property (No.2) Limited | Binding proteins |
| CN106645352B (zh) * | 2017-01-22 | 2019-01-18 | 浙江省医学科学院 | 一种用于检测血吸虫的纳米抗体组合物、免疫传感器及其制备方法和应用 |
| CN109942706A (zh) * | 2017-12-21 | 2019-06-28 | 三生国健药业(上海)股份有限公司 | 结合人il-5的单克隆抗体、其制备方法和用途 |
| EP3930687A4 (en) | 2019-02-25 | 2023-06-07 | The University of Chicago | METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS |
| CN113214394B (zh) * | 2020-10-30 | 2023-01-06 | 上海洛启生物医药技术有限公司 | 抗il5纳米抗体及其应用 |
| CN118401551A (zh) * | 2022-04-15 | 2024-07-26 | 上海韦青医药科技咨询有限公司 | 用于治疗皮肤及粘膜炎症的抗体及其制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1966242A1 (en) * | 2005-12-06 | 2008-09-10 | Domantis Limited | Ligands that have binding specificity for egfr and/or vegf and methods of use therefor |
| US20100047171A1 (en) * | 2006-01-24 | 2010-02-25 | Roland Beckmann | Fusion Proteins That Contain Natural Junctions |
| BRPI0710572A2 (pt) * | 2006-01-24 | 2013-01-08 | Domantis Limited | ligante, uso do ligante, mÉtodos para o tratamento de uma doenÇa alÉrgica, de asma e de cÂncer, para a inibiÇço de uma resposta imune do tipo th2, e administraÇço de tratamento anti-il-4 e tratamento anti-il-13, composiÇço farmacÊutica, dispositivo de dispensaÇço de droga, Ácido nucleico isolado ou recombinante, vetor, cÉlula hospedeira, mÉtodos para a produÇço de um ligante e de inibiÇço da proliferaÇço de cÉlulas |
| EP2535350B1 (en) * | 2007-09-26 | 2018-01-24 | UCB Biopharma SPRL | Dual specificity antibody fusions |
| TW200944231A (en) * | 2007-11-30 | 2009-11-01 | Glaxo Group Ltd | Antigen-binding constructs |
-
2010
- 2010-05-26 JP JP2012512354A patent/JP5901517B2/ja not_active Expired - Fee Related
- 2010-05-26 US US13/322,224 patent/US9394374B2/en active Active
- 2010-05-26 CA CA2763491A patent/CA2763491A1/en not_active Abandoned
- 2010-05-26 WO PCT/EP2010/057231 patent/WO2010136483A2/en not_active Ceased
- 2010-05-26 EP EP10727701.4A patent/EP2435482B1/en not_active Not-in-force
- 2010-05-26 ES ES10727701T patent/ES2729422T3/es active Active